RxDoctor Payments Data

Claire McDonough

Psychiatric/Mental Health · Austin, TXNPI 1023442142

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.6% of the total. 2025 is the largest year on record at $1,232, 4.4 times the $283 reported in 2021.

$3,650in general payments, 2019–2025

Across 190 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$934
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$387
  • Lundbeck LLC$314
  • Alkermes, Inc.$289
  • Otsuka America Pharmaceutical, Inc.$273
  • Takeda Pharmaceuticals U.S.A., Inc.$213
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,650100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,650 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trazodone Hcl13$161
Lorazepam11$24

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →